It is also worth highlighting that when parkinsonism is the only core clinical feature of DLB in a patient with dementia, reduced DAT uptake as indicative biomarkers warrants a probable DLB diagnosis [3]. This evidence concerns the gene SLC6A3 and Parkinsonism.